LLY

1,152.41

-2.04%↓

JNJ

231.8

-0.62%↓

ABBV

223.9

-0.76%↓

UNH

410.6

+2.54%↑

MRK

118.89

-2.67%↓

LLY

1,152.41

-2.04%↓

JNJ

231.8

-0.62%↓

ABBV

223.9

-0.76%↓

UNH

410.6

+2.54%↑

MRK

118.89

-2.67%↓

LLY

1,152.41

-2.04%↓

JNJ

231.8

-0.62%↓

ABBV

223.9

-0.76%↓

UNH

410.6

+2.54%↑

MRK

118.89

-2.67%↓

LLY

1,152.41

-2.04%↓

JNJ

231.8

-0.62%↓

ABBV

223.9

-0.76%↓

UNH

410.6

+2.54%↑

MRK

118.89

-2.67%↓

LLY

1,152.41

-2.04%↓

JNJ

231.8

-0.62%↓

ABBV

223.9

-0.76%↓

UNH

410.6

+2.54%↑

MRK

118.89

-2.67%↓

Accueil・Liste d'Actions・Incyte Corp
Search

Incyte Corp

Ouvert

SecteurSoins de santé

103.29 1.01

Achat

Actualisation du prix 9 juin 2026, 14:35 UTC

AcheterVendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

98.54

Max

103.53

Chiffres clés

By Trading Economics

Revenu

4.1M

303M

Ventes

-234M

1.3B

P/E

Moyenne du Secteur

13.501

49.888

BPA

1.81

Marge bénéficiaire

23.834

Employés

2,844

EBITDA

-47M

368M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+9.36% upside

Dividendes

By Dow Jones

Prochains Résultats

28 juil. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

49M

19B

Ouverture précédente

102.28

Clôture précédente

103.29

Sentiment de l'Actualité

By Acuity

47%

53%

151 / 344 Classement par Healthcare

Incyte Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

8 juin 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Salesforce to Buy m3ter in Nod Toward AI-Native Business Models

DJ

Lire

8 juin 2026, 15:41 UTC

Principaux Mouvements du Marché

American Battery Shares Jump on Energy Department Victory

DJ

Lire

8 juin 2026, 23:46 UTC

Market Talk

Nikkei May Rebound After Monday's Selloff -- Market Talk

DJ

Lire

8 juin 2026, 23:37 UTC

Market Talk

Oil Edges Higher Amid Ongoing Supply Disruption Concerns -- Market Talk

DJ

Lire

8 juin 2026, 23:25 UTC

Market Talk

Should Australia Consider State-Linked Commodities Export Desk? -- Market Talk

DJ

Lire

8 juin 2026, 23:25 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Lire

8 juin 2026, 21:57 UTC

Acquisitions, Fusions, Rachats

Salesforce Expects to Close Deal in 2Q of Fiscal 2027

DJ

Lire

8 juin 2026, 21:56 UTC

Acquisitions, Fusions, Rachats

Salesforce Agrees to Buy m3ter

DJ

Lire

8 juin 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Lire

8 juin 2026, 19:22 UTC

Market Talk

Oil Settles Higher as Israel-Iran Exchanges Raise Tension -- Market Talk

DJ

Lire

8 juin 2026, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back on Weather Outlook -- Market Talk

DJ

Lire

8 juin 2026, 18:52 UTC

Market Talk

Global Energy Roundup: Market Talk

DJ

Lire

8 juin 2026, 18:52 UTC

Market Talk

CAD Needs Trade Deal to Trigger Sustained Rally -- Market Talk

DJ

Lire

8 juin 2026, 18:17 UTC

Market Talk

Oil Pulls Back Further As Iran, Israel Put Strikes on Hold -- Market Talk

DJ

Lire

8 juin 2026, 17:32 UTC

Market Talk

Bank of Canada Should Incorporate Unemployment Rate Into Its Forecast -- Market Talk

DJ

Lire

8 juin 2026, 17:29 UTC

Market Talk

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

DJ

Lire

8 juin 2026, 17:29 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lire

8 juin 2026, 16:55 UTC

Acquisitions, Fusions, Rachats

Monte dei Paschi: Mediobanca Integration Proceeding According to Plan

DJ

Lire

8 juin 2026, 16:54 UTC

Acquisitions, Fusions, Rachats

Monte dei Paschi to Review Proposals From Banco BPM, Intesa Sanpaolo

DJ

Lire

8 juin 2026, 16:40 UTC

Market Talk

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

DJ

Lire

8 juin 2026, 16:31 UTC

Market Talk

No Recession in Canada, Scotiabank's CEO Says -- Market Talk

DJ

Lire

8 juin 2026, 16:27 UTC

Market Talk

Mexican Inflation Seen Easing in May -- Market Talk

DJ

Lire

8 juin 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Lire

8 juin 2026, 16:03 UTC

Acquisitions, Fusions, Rachats

Orange Bought Stake From Lorca

DJ

Lire

8 juin 2026, 16:01 UTC

Acquisitions, Fusions, Rachats

Orange Completes Acquisition of Remaining 50% Stake in MasOrange

DJ

Lire

8 juin 2026, 16:01 UTC

Acquisitions, Fusions, Rachats

Orange Acquires 100% Ownership of MasOrange

DJ

Lire

8 juin 2026, 15:58 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Lire

8 juin 2026, 15:58 UTC

Market Talk

Gold Trims Losses After Israel, Iran Halt Exchanges of Fire -- Market Talk

DJ

Lire

8 juin 2026, 15:55 UTC

Market Talk

Markets Price Small Chance USMCA Will Be Dismantled -- Market Talk

DJ

Lire

8 juin 2026, 15:41 UTC

Market Talk

Gold Falls Below 200-Day Moving Average -- Market Talk

DJ

Lire

Comparaison

Variation de prix

Incyte Corp prévision

Objectif de Prix

By TipRanks

9.36% hausse

Prévisions sur 12 Mois

Moyen 110.06 USD  9.36%

Haut 135 USD

Bas 75 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

8

Achat

10

Maintien

1

Vente

Basé sur 19 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

151 / 344Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Incyte Corp

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation

Autres valeurs du secteur

LLY

Eli Lilly and Co.

1,152.41

↓-2.04%

JNJ

Johnson and Johnson

231.8

↓-0.62%

ABBV

AbbVie Inc

223.9

↓-0.76%

UNH

UnitedHealth Group Inc

410.6

↑ +2.54%

MRK

Merck & Co Inc.

118.89

↓-2.67%
help-icon Live chat